ADA 2026 research showed how oral ketones, irisin, and SGLT2 inhibitors may reveal new metabolic pathways beyond glucose control.
Anne Komé, PharmD
Advertisement
Anne Komé, PharmD, CPP, BCACP, CDCES, is a clinical pharmacist practitioner in the Endocrinology Clinic at the UNC Chapel Hill Medical Center.
Articles by Anne Komé, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
3
Social Factors Shape Diabetes, Dementia Risk Across Populations
4
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
5